Boston Partners raised its holdings in Ingevity Corporation (NYSE:NGVT – Free Report) by 13.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 442,175 shares of the company’s stock after purchasing an additional 52,492 shares during the quarter. Boston Partners owned 1.31% of Ingevity worth $31,287,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of NGVT. BlackRock Inc. acquired a new position in shares of Ingevity during the 2nd quarter worth $400,545,000. Dimensional Fund Advisors LP grew its position in Ingevity by 3.0% in the first quarter. Dimensional Fund Advisors LP now owns 798,709 shares of the company’s stock valued at $56,889,000 after acquiring an additional 23,219 shares during the last quarter. Bessemer Group Inc. grew its position in Ingevity by 18.2% in the third quarter. Bessemer Group Inc. now owns 452,304 shares of the company’s stock valued at $31,999,000 after acquiring an additional 69,541 shares during the last quarter. Rice Hall James & Associates LLC acquired a new position in Ingevity during the second quarter worth about $26,224,000. Finally, Russell Investments Group Ltd. raised its stake in Ingevity by 45.5% during the third quarter. Russell Investments Group Ltd. now owns 364,320 shares of the company’s stock worth $25,776,000 after acquiring an additional 113,989 shares in the last quarter. Institutional investors own 91.59% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on NGVT shares. Wall Street Zen cut shares of Ingevity from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. BMO Capital Markets decreased their price target on shares of Ingevity from $85.00 to $72.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Weiss Ratings raised shares of Ingevity from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, November 4th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Ingevity presently has a consensus rating of “Hold” and a consensus price target of $76.33.
Ingevity Stock Down 4.1%
Shares of NYSE:NGVT opened at $53.66 on Friday. The firm has a market cap of $1.81 billion, a P/E ratio of 31.56 and a beta of 1.12. Ingevity Corporation has a 12-month low of $48.00 and a 12-month high of $79.29. The business has a fifty day simple moving average of $68.53 and a 200 day simple moving average of $70.85. The company has a quick ratio of 1.05, a current ratio of 1.48 and a debt-to-equity ratio of 15.70.
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $1.63 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.07. Ingevity had a return on equity of 405.38% and a net margin of 5.28%. The company had revenue of $305.10 million during the quarter, compared to analysts’ expectations of $303.91 million. Analysts predict that Ingevity Corporation will post 5.38 earnings per share for the current year.
Ingevity Profile
Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world.
Further Reading
- Five stocks we like better than Ingevity
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
